methyl ester (L-NAME; 20 mg kg day )-induced hypertension. Methods: Forty Wistar rats were divided into four groups: control, losartan, L-NAME, and losartan1L-NAME. The responses of isolated mesenteric arterial rings were examined in standard organ chambers after 8 treatment weeks. Results: Losartan therapy prevented the development of L-NAME-induced hypertension and the associated impairments of endothelium-independent relaxations to nitroprusside, isoprenaline, and cromakalim, vasodilators acting via the 1 formation of NO, activation of b-adrenoceptors and opening of K channels, respectively. In addition, endothelium-dependent relaxations of noradrenaline-precontracted rings to acetylcholine during NO synthase inhibition in vitro were decreased in L-NAME rats, and clearly improved by losartan therapy. The inhibition of cyclooxygenase by diclofenac improved the responses to acetylcholine more effectively in L-NAME than losartan1L-NAME rats, but the relaxations remained decreased in L-NAME rats when compared with losartan1L-NAME rats. When hyperpolarization of smooth muscle was prevented by precontractions induced by high concentration of KCl, the responses to acetylcholine during combined NO synthase and cyclooxygenase inhibition were similar and almost abolished in all groups. Furthermore, superoxide dismutase, a scavenger of superoxide anions, enhanced the acetylcholine-induced relaxations more effectively in L-NAME than losartan1L-NAME rats, although plasma antioxidant capacity was similar in all study groups. Conclusion: Chronic L-NAMEinduced hypertension was associated with attenuated arterial relaxation via endothelium-dependent and -independent mechanisms, both of which were improved by the losartan treatment. The mechanisms whereby losartan enhanced arterial relaxation in this model of experimental hypertension may have included enhanced hyperpolarization and increased sensitivity to NO in smooth muscle, and decreased vascular production of superoxide and vasoconstrictor prostanoids.
Introduction action of NO [2]
, which makes chronic NO-deficiency a G particularly interesting model of hypertension. N -nitro-LThe endothelial production of nitric oxide (NO) is arginine methyl ester (L-NAME) is a structural analogue essential for the maintenance of normal blood pressure [1] .
of L-arginine and a potent competitive inhibitor of NO Several disease states including essential hypertension synthase (NOS) [3] . Accordingly, chronic administration have been associated with defects in the production or of L-NAME has been shown to result in sustained hypertension in normotensive rats [4, 5] , with an associated impairment of endothelium-dependent arterial relaxations [6] [7] [8] [9] . However, the findings concerning arterial responses administration, losartan therapy and fortnightly blood to exogenous NO and various contractile agonists have pressure measurements were continued for 8 more weeks, been somewhat inconsistent in this model [6] [7] [8] .
whereafter the rats were anaesthetized by intraperitoneal 21 The angiotensin II (Ang II) receptor antagonist losartan administration of urethane (1.3 g kg ). The carotid artery exerts its antihypertensive action primarily through the was cannulated and blood samples were drawn into chilled competitive inhibition of Ang II binding to the AT tubes on ice containing 2.7 mmol EDTA. The plasma 1 receptors. However, the antagonism of thromboxane A / samples were centrifuged, and stored at 2708C until 2 prostaglandin H receptors [10] and increased production assayed. The hearts were removed and weighed, and the 2 of NO and vasodilatory prostanoids [11] have also been superior mesenteric arteries and small mesenteric artery suggested to contribute to the long-term antihypertensive segments were excised. The experimental design of the effects of losartan in experimental animals. Both losartan study was approved by the Animal Experimentation Com- [12, 13] and angiotensin converting enzyme (ACE) inmittee of the University of Tampere, Finland, and the hibitors [7, 14] have been shown to prevent the developinvestigation conforms with the Guide for the Care and ment of the L-NAME-induced hypertension, and ACEUse of Laboratory Animals published by the US National inhibitors have also been shown to improve endotheliumInstitutes of Health (NIH publication No. 85-23, revised dependent relaxations [6, 9] and prevent the attenuation of 1996). arterial contractile responses in this experimental model [7] . Nevertheless, the influence of Ang II receptor antago-2.2. Mesenteric arterial responses in vitro nist treatment on arterial function in L-NAME hypertensive rats has not been elucidated.
The inhibitory effect of orally administered L-NAME on Since the inhibitory effect of orally administered Lacetylcholine (ACh)-induced relaxation has been found to NAME does not persist in vitro, the investigations on the decline during successive responses in isolated arterial control of arterial tone in L-NAME hypertension are preparations from L-NAME-treated rats [5] . In preliminary somewhat difficult to perform [5] . The decline of NOS experiments we also observed that arterial relaxation to inhibition ex vivo could be counteracted by the addition of ACh from L-NAME hypertensive rats improved during L-NAME to the organ bath, the approach of which, repeated challenges. We tested the in vitro concentrations however, has not been applied in the previous reports. The of 0.1-100 mM L-NAME and found that 100 mM of present study was designed to examine the effects of L-NAME was needed to prevent the enhancement of long-term losartan-therapy on the control of arterial tone in relaxation to ACh during four repetitions. Therefore, the L-NAME hypertensive Wistar rats, and the decline of NOS majority of the in vitro experiments were performed in the inhibition in vitro was eliminated by the addition of Lpresence of 0.1 mM L-NAME as given below. NAME to the bioassay. Special attention was paid to Five successive standard sections (3 mm in length) of evaluate the roles of different endothelium-derived medithe main superior mesenteric artery from each animal were ators in the vasodilator responses and to elucidate the cut, beginning 5 mm distally from the mesenteric arterypossible functional changes in arterial smooth muscle. aorta junction. In the three most distal rings the endothelium was left intact, and from the first two pieces it was removed [15] . The rings were suspended in an organ bath chamber in physiological salt solution (PSS; pH 7. were equilibrated for 1 h at 1378C with a resting preload Male Wistar rats were housed four to a cage in an of 1.5 g, and contraction was measured with isometric experimental animal laboratory (illuminated 06:00-18:00 force-displacement transducer and registered on a polyh, temperature 1228C) with free access to drinking fluid graph (FT 03 transducer and Model 7 E Polygraph; Grassä nd food pellets (Ewos, Sodertalje, Sweden). The systolic Instrument Co., Quincy, MA, USA). The presence of intact blood pressures of the conscious animals were measured at endothelium is often confirmed by a clear relaxation to 1 1288C by the tail-cuff method (Model 129 Blood Pressure mM ACh in 1 mM noradrenaline (NA)-precontracted rings, Meter; IITC Inc., Woodland Hills, CA, USA). At 11 weeks and the absence of endothelium by the lack of this of age the rats were divided into four groups (n510) of response [15] . However, in the present investigation the equal mean systolic blood pressures and the drugs were responses to ACh were almost completely absent in the added to the drinking fluid as follows: control (tap water); L-NAME group. Therefore, no vascular preparations were 21 21 21 losartan (20 mg kg day ); L-NAME (20 mg kg excluded from the study.
21
day ); and losartan1L-NAME (doses of both losartan 21 21 and L-NAME 20 mg kg day ). Drug solutions were 2.2.1. Vascular preparation 1 prepared daily and given in light-proof bottles. L-NAME Contractions of endothelium-denuded rings to KCl were cumulatively determined. In solutions containing high allowed a 30 min equilibration period in PSS containing concentrations of potassium (20-125 mM), NaCl was the above enzyme(s) between each cumulative relaxation. replaced with KCl on an equimolar basis. After the 21 response the rings were rinsed with Ca -free PSS, and, 2.3. Morphological studies once the resting tension was restored, the rings were 21 contracted twice with 10 mM NA in Ca -free PSS to Third order mesenteric arterial branches were chosen 21 deplete the cellular Ca stores. The rings were challenged from the vascular bed that feeds the small intestine 2-6 cm 21 21 with 125 mM KCl in Ca -free PSS, whereafter Ca was prior to the ileocecal junction. A segment (2 mm in length) cumulatively added (0.01-2.5 mM) and the contraction of the mesenteric artery was isolated under a dissection 21 registered [16] . Then the rings were rinsed with Ca -free microscope (Nikon SMZ-2T, Nikon Inc., Japan) and PSS and allowed a 20-min recovery period, and the same transferred to the myograph chamber (Living Systems procedure was elicited in the presence of 0.5 nM Instrumentation Inc., Burlington, VT, USA) containing 8 nifedipine, and in the presence of nifedipine and 0.05 mM ml of PSS (pH 7.4) of the following composition (mM): mibefradil. All responses were performed in the presence NaCl 119.0, NaHCO 25.0, glucose 11.1, CaCl 2.5, KCl vasodilator. The responses in the L-NAME and losartan1 pressure was slowly raised to 60 mmHg. The pressure in L-NAME groups were performed in the presence of 0.1 the proximal end of the artery segment was monitored by a mM L-NAME. pressure transducer and controlled by a servo perfusion system (Pressure servo control, Living Systems Instrumentation Inc., Burlington, VT, USA). After the vessel had 2.2.3. Vascular preparation 3 equilibrated for 40 min in 60 mmHg the arterial dimenContractions to NA were determined in endotheliumsions were recorded. intact rings in the presence of 0.1 mM L-NAME. The responses to NA were also elicited in the presence of 2.4. Total peroxyl radical-trapping and vitamin E L-NAME and 3 mM diclofenac. The rings were allowed a 30 min equilibration period in PSS containing the above Total peroxyl radical-trapping capacity was determined inhibitors between the two determinations.
by the chemiluminescense method which has been described elsewhere [17] . Briefly, the production of peroxyl radicals by ABAP (2,29-azobis[2-amidinopropane] hydro-2.2.4. Vascular preparation 4 chloride) induces luminol-enhanced chemiluminescence, Relaxations to ACh in the presence of 0.1 mM Land the time during which the added test sample exting-NAME, and in the presence of L-NAME and 3 mM uishes the reaction is directly proportional to its peroxyl diclofenac were examined in endothelium-intact rings radical-trapping antioxidant capacity. The test reaction was precontracted with 1 mM NA. The responses to ACh in the initiated by mixing 475 ml of oxygen-saturated sodium presence of L-NAME plus 3 mM diclofenac were also phosphate buffer (100 mM, pH 7.4) with 50 ml of 400 mM elicited in rings precontracted with 50 mM KCl. The rings ABAP (prepared in 100 mM phosphate-buffer) and 50 ml were allowed a 30 min equilibration in PSS containing the of 10 mM luminol in 20 mM boric acid-Borax-buffer in a above inhibitors between each cumulative relaxation.
cuvette (pH 9.0). The cuvette was placed in a luminometer (378C), and the plasma sample (25 ml) was injected after the luminescence had stabilized, whereafter the chemi-2.2.5. Vascular preparation 5 luminescence was measured at 40 s intervals. The waterRelaxations to ACh in the presence of 0.1 mM L-NAME soluble tocopherol was used as a standard. Vitamin E were examined in endothelium-intact arterial rings preconcentration was determined by modified high performcontracted with 1 mM NA. The responses to ACh were ance liquid chromatography (HPLC) [18] , and in our also elicited in the presence of L-NAME plus 50 U / ml modification the UV detection of antioxidants was replaced superoxide dismutase (SOD), and in the presence of Lby an LC-4 amperometric detector (Bioanalytical Systems NAME, SOD plus 100 U / ml catalase. The rings were Inc. West Lafayette, USA).
Data presentation and analysis of results
The maximal contractile responses to NA and KCl were expressed in grams. The EC for NA and KCl as well as 50 
EC
for calcium in each ring was calculated as a 25 percentage of maximal response and presented as the negative logarithm (pD and pD , respectively), which 50 25 values were also used in the statistical analysis. The pD 25 values were chosen for the statistics in the contractile responses to cumulative calcium, since the responses did not reach the level of 50 per cent in the presence of the inhibitors. The relaxations in response to ACh, NP, isoprenaline and cromakalim were presented as a percentage of pre-existing contractile force. Statistical analysis was carried out by one-way analysis of variance (ANOVA) supported by the Bonferroni test when carrying out pairwise comparisons between the test groups. ANOVA for repeated measurements was applied for data consisting of repeated observations at successive time points. Unless otherwise indicated the P values in the were considered significant when P,0.05.
Drugs
were corresponding in all groups. The heart-body weight ratios were comparable in L-NAME and control groups, The following drugs were used: losartan potassium whereas the losartan therapy reduced relative heart weights (Merck Pharmaceutical Company, Wilmington, DE, USA), in both of these groups. Plasma total peroxyl radicalacetylcholine chloride, catalase, cromakalim, isoprenaline trapping capacities and vitamin E concentrations were G hydrochloride, N -nitro-L-arginine methyl ester hydrochlocomparable between the study groups (Table 1) . ride, superoxide dismutase (Sigma Chemical Co, St Louis, MO USA), L-noradrenaline L-hydrogentartrate, nitroprus-3.2. Endothelium-independent relaxations of the side (Fluka Chemie AG, Buchs SG, Switzerland), dimesenteric artery ® clofenac (Voltaren injection solution, Ciba-Geigy, Basel, Switzerland) and nifedipine (Orion Pharma Ltd., Espoo, In order to make proper interpretations from the endoFinland). For the preparation of stock solutions the comthelium-dependent relaxations, the vasodilatory properties pounds used in the in vitro studies were dissolved in of arterial smooth muscle were examined. The relaxations distilled water, with the exception of cromakalim and of endothelium-denuded NA-precontracted rings to NP, nifedipine (in 50% ethanol). All solutions were freshly isoprenaline and cromakalim, the vasodilators acting via prepared before use and protected from light. Losartan and the formation of NO, activation of b-adrenoceptors and
N -nitro-L-arginine methyl ester hydrochloride were disopening of ATP-sensitive K channels (K ), respective-ATP solved directly in the drinking water of the rats. ly, were impaired in L-NAME rats when compared with all other groups. All of these impairments in arterial relaxation were clearly improved by the losartan treatment. In 3. Results addition, when hyperpolarization of smooth muscle was prevented by precontractions with 50 mM KCl [19] , the 3.1. Blood pressure, body and heart weights, plasma relaxations to NP were still impaired in L-NAME rats and total peroxyl radical-trapping and vitamin E normalized by losartan (Fig. 2) .
Long-term administration of L-NAME resulted in an 3.3. Endothelium-dependent relaxations elevation of blood pressure which reached its maximum within 4 weeks, while the losartan treatment effectively
The relaxations induced by ACh in NA-precontracted prevented the development of hypertension. There was no arterial rings in the presence of L-NAME were markedly significant difference in the systolic blood pressure of the impaired in the L-NAME group when compared with the control group when compared with the losartan group control group, while these responses were clearly imduring the follow-up period (Fig. 1) . The body weights proved by losartan treatment in both of these groups ( 3A). The addition of the cyclooxygenase (COX) inhibitor ANOVA) (Fig. 3B) . The responses to ACh were almost diclofenac to the organ bath improved the relaxations to abolished in all groups when induced in KCl-precontracted ACh in all other groups (P,0.05), but not in the losartan rings in the presence of L-NAME and diclofenac (Fig.  group, and abolished the difference between the control 3C). and losartan groups, while the relaxations still remained When SOD was added to the organ bath the relaxations impaired in the L-NAME group when compared with the to ACh were enhanced in all other groups (P,0.05), but other groups. On the other hand, diclofenac caused a not in the losartan group, while the responses to ACh 5.2-fold increase in the maximum relaxation to ACh in the remained impaired in the L-NAME group when compared L-NAME group when compared with the 1.6-fold change with the other groups (Fig. 3D) . However, the addition of in the losartan1L-NAME group (P,0.05, one-way SOD caused a 3.4-fold increase in the maximum response Fig. 2 . Line graphs show relaxations to nitroprusside after precontraction with 1 mM noradrenaline (A) and 50 mM KCl (B), and relaxations to isoprenaline (C) and cromakalim (D) after precontraction with 1 mM noradrenaline in endothelium-denuded mesenteric arterial rings. The groups were control (s), losartan (h), L-NAME (d), and losartan1L-NAME (j). L-NAME in vitro (0.1 mM) was present in the two latter groups, values represent mean6SEM, n58-10 in each group; * P,0.05, ANOVA for repeated measurements. Fig. 3 . Line graphs show relaxations to acetylcholine in endothelium-intact mesenteric arterial rings. The relaxations were induced after precontraction with 1 mM noradrenaline in the presence of 0.1 mM L-NAME (A), in the presence of L-NAME plus 3 mM diclofenac (B), and after precontraction with 50 mM KCl in the presence of L-NAME plus diclofenac (C). The relaxation was also induced after precontraction with 1 mM noradrenaline in the presence of L-NAME plus 50 U / ml superoxide dismutase (D). The groups were control (s), losartan (h), L-NAME (d), and losartan1L-NAME (j). Values represent mean6SEM, n58-10 in each group; * P,0.05, ANOVA for repeated measurements.
to ACh in the L-NAME group when compared with the contractile force, was somewhat higher in losartan1L-1.5-fold change in the losartan1L-NAME group (P,0.05, NAME group (Table 2) . one-way ANOVA). In addition, SOD abolished the differThe contractile sensitivity of arterial smooth muscle (i.e. 21 ence in response to ACh between the control and losartan pD values) to the cumulative addition of Ca during 25 group (Fig. 3D) . The further addition of catalase had no depolarization with KCl was similar in all study groups 21 significant effects on the relaxation to ACh in any of the (Table 2) . Moreover, the L-type Ca entry blocker study groups (data not shown).
nifedipine equally decreased arterial contractile sensitivity 21 to Ca in the control, losartan, and L-NAME groups, 3.4. Vasoconstrictor responses while the effect of nifedipine was smaller in the losartan1 21 L-NAME group. In contrast, the T-type Ca entry blocker 21 The contractile experiments were performed to elucidate mibefradil, when added after nifedipine, reduced the Ca the possible differences in vasoconstriction which may sensitivity of arterial smooth muscle more effectively in curtail the results on arterial relaxation. The maximal the L-NAME group than in the other groups. Losartan contractile force generation to NA in the presence of treatment was without effect on the inhibitory effect of 21 L-NAME was comparable in control, L-NAME, and mibefradil on the Ca sensitivity in either group (Table  losartan1L -NAME groups, while the maximal contraction 2). was lower in losartan group (Table 2 ). The vasoconstrictor sensitivity (i.e. pD values) to NA in the presence of 3.5. Morphological studies 50 L-NAME, and in the presence of L-NAME and diclofenac, was similar in all study groups. In addition, the arterial The wall thickness and wall to lumen ratio of the rings of the control, losartan, and L-NAME groups showed mesenteric resistance arteries from L-NAME rats were similar contractile force generation and sensitivity to KCl, higher than in those from control rats in both pressurized whereas arterial contractile sensitivity, but not the maximal and unpressurized arteries. The wall thickness and wall to Values are mean6SEM, n58-10 for all groups. 1E and 2E, endothelium intact and endothelium-denuded arterial rings, respectively. pD and pD are negative logarithms of the concentration of agonist producing 50% and 25% of maximal contractile force, respectively. lumen ratio of the losartan1L-NAME rats did not differ 4 weeks, whereas losartan therapy totally prevented the from those of the control rats when the measurements were elevation of blood pressure, which agrees with previous performed without intraluminal pressure. However, the experiments on ACE inhibitors [7, 14, 20] and losartan effect of losartan on wall thickness and wall to lumen ratio [13, 21] . In addition, losartan has even been shown to was absent when the dimensions were measured under 60 reverse established L-NAME hypertension in rats [22] . mmHg of pressure. No differences were observed in the However, the present results for the first time showed that external diameter of pressurized and unpressurized arteries the impairments of endothelium-dependent and -indepenbetween the study groups (Table 3) . dent arterial relaxation associated with NO-deficient hypertension can effectively be antagonized by chronic Ang II receptor antagonism.
Discussion
The heart weight-body weight ratios did not differ between the L-NAME and control rats in this study, which Chronic inhibition of NOS is a new model of hypertenagrees with some previous reports [12, 23] , although consion [4] . In this study L-NAME administration resulted in tradictory findings have been published [14, 24] . Despite a marked hypertension which reached its maximum within the absence of cardiac hypertrophy in the L-NAME rats, Table 3 Morphological measurements in isolated small mesenteric arteries in the study groups Control Losartan L-NAME Los1L-NAME losartan therapy reduced heart weights in this study. effectively antagonized by concomitant losartan therapy. Previously, the stimulation of AT -receptors has been Moreover, losartan improved endothelium-mediated vaso-2 shown to exert an antigrowth effect on rat cardiomyocytes dilatation in the normotensive control rats, a finding which [25] , which could explain the effect of losartan on heart has also been observed with ACE inhibitors [33] . weights, since AT -receptor antagonism leads to the The chemical antagonism between superoxide and NO is 1 accumulation of Ang II, which results in increased stimularecognized as an important modulator of vascular tone. In tion of the unopposed AT -receptors [26, 27] .
addition, superoxide has been reported to inhibit the 2 We found that oral L-NAME induced arterial hypervascular synthesis of PGI without affecting that of the 2 trophy in the mesenteric resistance vessels, which is in vasoconstrictor thromboxane A [34]. Therefore, superox-2 concert with previous reports [5, 24, 28] . In the spontaide production or decreased antioxidant activity in the neously hypertensive rat (SHR) losartan has been reported cardiovascular system could increase arterial tone and to decrease arterial hypertrophy when microscopic examicontribute to the development of hypertension. In the nations were performed in paraffin-embedded preparations present study, the total peroxyl radical-trapping capacity [29] , and the present measurements in unpressurized and vitamin E concentration in plasma were comparable in arteries yielded parallel results. However, the measureall groups, suggesting that L-NAME hypertension is not ments in pressurized arteries, which represent a more associated with changes in circulating antioxidant capacity. physiological state, did not show differences between the In contrast, losartan treatment appeared to reduce the L-NAME and losartan1L-NAME groups. Thus, losartan production of superoxide in the arteries of L-NAME rats, therapy did not reduce arterial hypertrophy in the Lsince the enhancing effect of SOD, the superoxide anion NAME rats even though it normalized their blood presscavenger, on the relaxations to ACh was more prosure. Therefore, vascular hypertrophy in this model of nounced in the L-NAME group when compared with the hypertension appears to be independent of blood pressure, losartan1L-NAME group. Moreover, the difference in the and may result from decreased vascular NO production, relaxation induced by ACh between the control and since endothelium-derived NO has been shown to inhibit losartan group was abolished by SOD, suggesting that smooth muscle growth [30] .
losartan therapy reduced the production of superoxide also The arterial relaxations induced by the NO-donor nitroin control rats. The view of reduced superoxide production prusside have been suggested to be enhanced [7, 8] , or by losartan is in agreement with previous results whereby remain unaffected in L-NAME hypertension [6] . However, losartan-treatment decreased the production of superoxide in our study the L-NAME rats showed attenuated relaxaand normalized the ACh-induced arterial relaxations in tions to nitroprusside in both NA-and KCl-precontracted Ang II hypertensive rats [35] . vascular rings, suggesting that the sensitivity of arterial
The production of vasoconstrictor prostanoids has been smooth muscle to NO was decreased. In addition, the suggested to contribute to the impaired endothelium-merelaxations induced by the b-adrenoceptor agonist isodiated vasodilatation in L-NAME hypertension [6] . In this prenaline and the K opener cromakalim were also study, the inhibition of COX by diclofenac clearly en-ATP impaired in the L-NAME rats. Therefore, L-NAME hyhanced the relaxations to ACh in the L-NAME and pertension was associated with attenuated vasorelaxant losartan1L-NAME groups, suggesting that COX-derived 1 responses via cGMP, cAMP and the opening of K contractile factors were involved in these responses. Morechannels, which suggests a general impairment of relaxaover, losartan appeared to reduce the production of these tion in arterial smooth muscle. Since all these impairments factors in L-NAME rats, since the shift in the relaxation to have also been described in SHR [31] , they are likely to ACh following diclofenac was more pronounced in the result from the long-term elevation of blood pressure. This L-NAME group when compared with the losartan1L-view is supported by the fact that the present antihyper-NAME group. The release of vasoconstrictor prostanoids tensive effect of losartan was accompanied by a complete was probably also reduced in the control rats by losartan, normalization of these changes.
since the difference in the relaxations to ACh between the ACh dilates arteries via the release of several factors control and losartan groups was abolished by diclofenac. It from the endothelium, the most prominent of these being is noteworthy that decreased superoxide production may NO, prostacyclin (PGI ) and the endothelium-derived also have contributed to the enhanced endothelium-me-2 hyperpolarizing factor (EDHF) [32] . Arterial relaxations to diated vasodilatation after diclofenac administration, since ACh have been shown to be impaired in L-NAME COX is a significant source of superoxide [34] . hypertensive rats [6] [7] [8] 20] , and trandolapril has been The endothelium-dependent relaxations which are resissuggested to prevent this impairment [6, 20] . Furthermore, tant to both NOS and COX inhibitions are probably flow-induced dilatation has been reported to be attenuated mediated by EDHF [36] . The chemical characteristics of 1 in L-NAME hypertension, the attenuation of which was EDHF are unknown, but functionally this factor is a K prevented by quinapril [9] . In agreement with these channel opener [36] , the action of which can be inhibited 1 findings, the relaxations of arterial rings to ACh were by K channel blockers or by cell membrane depolariza-1 markedly impaired in the present L-NAME rats, and tion with high K concentration [19] . Although all present study groups showed distinct NOS and COX inhibitorciated with the impairment of endothelium-dependent and resistant relaxations to ACh, the remaining responses in -independent vasorelaxation in the mesenteric artery of the the L-NAME group were attenuated when compared with Wistar rat. Long-term antihypertensive treatment with all others, while the responses in the losartan1L-NAME losartan prevented the impairment of endothelium-indepengroup did not differ from the control group. Thus, losartan dent vasodilatation, and improved endothelium-mediated prevented the impairment of endothelium-dependent hyrelaxation. The mechanisms underlying the improved perpolarization in L-NAME-treated rats. The precontracvasodilatation following losartan therapy in NO-deficient tion of arterial rings with KCl almost abolished the hypertension may include enhanced arterial hyperpolarizaremaining NOS and COX inhibitor-resistant relaxations to tion, increased sensitivity to NO in smooth muscle, and ACh, suggesting that these responses were mediated by decreased vascular production of superoxide and vasocon-EDHF. It is noteworthy that NO has been shown to inhibit strictor prostanoids. the production and action of EDHF [37, 38] . Therefore, in pathophysiological states like hypertension, which may be associated with decreased bioavailability of NO, EDHFAcknowledgements mediated vasorelaxation could be of greater importance than under normal conditions [37] . Nevertheless, decreased This study was supported by the Medical Research Fund endothelium-dependent hyperpolarization has been reof Tampere University Hospital, the Aarne Koskelo ported in genetic, renal, and mineralocorticoid-NaCl forms Foundation, the Ida Montin Foundation, the Einar and of experimental hypertension [39] [40] [41] , and the present Karin Stroems Foundation, and an Educational Grant from results suggest that the same also holds true for L-NAME MSD. hypertension.
Impaired endothelium-dependent hyperpolarization could result from reduced sensitivity of smooth muscle to References EDHF or from decreased endothelial release of EDHF. The present results whereby the relaxations induced by the suggest that the sensitivity of smooth muscle to hyper- has been reported to hyperpolarize arterial smooth muscle The present study confirmed the earlier finding whereby rats. Previously, a 3-week administration of L-NAME has 
